Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
100.10
+2.60 (2.67%)
At close: Oct 5, 2026, 4:00 PM EDT
100.35
+0.25 (0.25%)
Pre-market: Oct 6, 2026, 5:21 AM EDT
Abbott Laboratories Stock Forecast
Stock Price Forecast
According to 27 analysts polled by S&P Global, Abbott Laboratories stock has a consensus rating of "Buy" and an average price target of $120.26. The average 1-year stock price forecast is 20.14% higher than the current stock price, while the lowest is $103 (+2.90%) and the highest is $135 (+34.87%).
Price Target: $120.26 (+20.14%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Abbott Laboratories stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 16 | 16 | 17 | 16 | 17 | 18 |
| Buy | 5 | 4 | 4 | 4 | 4 | 4 |
| Hold | 7 | 7 | 7 | 7 | 6 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 28 | 27 | 28 | 27 | 27 | 27 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Maintains $125 | Buy | Maintains | $125 | +24.88% | Oct 5, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $112 | Buy | Maintains | $112 | +11.89% | Oct 5, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $115 | Buy | Maintains | $115 | +14.89% | Oct 2, 2026 |
| Rothschild & Co Redburn | Rothschild & Co Redburn | Buy Upgrades $119 → $127 | Buy | Upgrades | $119 → $127 | +26.87% | Oct 2, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $130 | Buy | Maintains | $130 | +29.87% | Oct 1, 2026 |
Financial Forecast
Revenue This Year
50.20B
from 44.33B
Increased by 13.26%
Revenue Next Year
54.53B
from 50.20B
Increased by 8.62%
EPS This Year
5.52
from 5.15
Increased by 7.17%
EPS Next Year
6.07
from 5.52
Increased by 9.90%
EPS and Forward PE are based on non-GAAP adjusted numbers.